Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Donanemab
Sneak Peek of Trial Data for Alzheimer’s Drug Donanemab
FDA Declines Rush Request for Alzheimer’s Drug Donanemab
Why Alzheimer’s Trials Are Recruiting Younger Patients
Gantenerumab for Alzheimer’s Gets FDA ‘Breakthrough’ Status
Meet Lilly’s Investigational Alzheimer’s Drug Donanemab: A Q&A With Dr. David Weidman
FDA Speeds Up Process for Two More Anti-Amyloids
What’s Next for Eli Lilly Alzheimer’s Drug Donanemab? Trial Enrollment Continues
Does Eli Lilly’s Alzheimer’s Drug Donanemab Work? Key New Data Released
Previous
1
2
Page load link
Go to Top
